These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17640191)

  • 1. Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center.
    Andrès E; Lorenzo Villalba N; Mourot-Cottet R; Maloisel F; Tebacher M; Gottenberg JE; Goichot B; Herbrecht R; Zulfiqar AA
    Medicines (Basel); 2020 Mar; 7(3):. PubMed ID: 32204561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.
    Andrès E; Villalba NL; Zulfiqar AA; Serraj K; Mourot-Cottet R; Gottenberg AJ
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31480527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases.
    Mourot-Cottet R; Maloisel F; Séverac F; Keller O; Vogel T; Tebacher M; Weber JC; Kaltenbach G; Gottenberg JE; Goichot B; Sibilia J; Korganow AS; Herbrecht R; Andrès E
    Drugs Real World Outcomes; 2016 Dec; 3(4):393-399. PubMed ID: 27747601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aplastic anemia associated with oral terbinafine: a case report and review of the literature.
    Kantarcıoğlu B; Türköz HK; Yılmaz G; Pepedil Tanrıkulu F; Kaygusuz Atagündüz I; Adıgüzel C; Fıratlı Tuğlular T
    Turk J Haematol; 2014 Dec; 31(4):411-6. PubMed ID: 25541660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
    Cribier BJ; Bakshi R
    Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
    Aguilar C; Mueller KK
    J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
    Ornstein DL; Ely P
    J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
    [No Abstract]   [Full Text] [Related]  

  • 9. Terbinafine: agranulocytosis.
    Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590912
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toenails and agranulocytosis.
    Pillans PI; Boyd IW
    Intern Med J; 2007 Aug; 37(8):572-5. PubMed ID: 17640191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
    Andrès E; Maloisel F
    Curr Opin Hematol; 2008 Jan; 15(1):15-21. PubMed ID: 18043241
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.